Analyst firms · Citigroup · KOD
Citigroup KOD price target and rating history
Kodiak Sciences Inc (KOD) · Health Care
Citigroup rates Kodiak Sciences Inc (KOD) Sell with a $6 price target, as of its latest action on Aug 2, 2022. It has published 4 rating actions on KOD since November 2021, including 0 upgrades and 1 downgrade. Across 3 firms with a KOD price target in the last 12 months, the median target is $36.
- Current rating
- Sell
- Price target
- $6
- Median target, all firms
- $36
- Actions on KOD
- 4
Citigroup price target on KOD
Every Citigroup rating on KOD
- Aug 2, 2022
- Feb 24, 2022
- Jan 26, 2022
- Nov 11, 2021
How other firms rate KOD
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Goldman Sachs | Neutral | $36 | Sep 24, 2026 |
| Chardan Capital Markets | Buy | $61 | May 11, 2026 |
| H.C. Wainwright | Buy | $24 | Nov 11, 2025 |
Questions about Citigroup and KOD
- What is Citigroup's price target for KOD?
- Citigroup's latest stated price target for Kodiak Sciences Inc (KOD) is $6, from its action on Aug 2, 2022.
- What is Citigroup's rating on KOD?
- Citigroup rates KOD Sell, a bearish rating, as of Aug 2, 2022.
- When did Citigroup last change its view on KOD?
- On Aug 2, 2022, Citigroup downgrades to Sell from Neutral, price target $6.
- How does Citigroup's KOD target compare with other analysts?
- Across 3 firms with a KOD price target in the last 12 months, the median target is $36.
More KOD rating histories
All Citigroup ratingsKOD news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.